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Abstract 
Seizures cause selective neuronal cell loss in vulnerable regions such as 
the hippocampus, cortex, thalamus or substantia nigra (SN) in human or 
experimental animals. While the HF can propagate seizures, the SN pars 
reticulata (SNR) regulates the spread ol seizures in an age-dependent fashion, 
and the pars compacta (SNC) affects extrapyramidal motor control. In mature 
animals, both structures are wlnerable to seizure-induced damage. In 
prepubescent rats, seizure susceptibility is reduced and CA 1 region rs primarily 
affected. The proto-oncogenes, Bcl-2 and Bax, encode specific proteins that 
inhibit and promote programmed cell death, respectively. In order to determine 
whether proto-oncogenes are involved in cell death or survival, we examined 
mRNA and protein expression of Bax and Bcl-2 during several maturational 
I 
(P13, P20, P30) stages. We used in silu hybridization and 
immunohistochemistry following a single episode of KA-induced status 
epilepticus. At P13, there was no apparent change in the expression levels of 
Bax or Bcl-2 mRNA or protein within the hippocampus, 48h after status 
epilepticus. In contrast, Bcl-2 proteins markedly declined within the SN sub- 
regions at P20 and P30, stages lhal do not exhibit SN damage at the times 
examined. Similar observations were found in the hippocampus at P20 and 
P30, except that their expression decreased in areas of cell injury or neuronal 
loss. Adjacent sections showed that tyrosine hydroxylase (TH) and glutamic 
t 
acid decarboxylase GAD levels were undisturbed in the SN. These result 
suggest that proto-oncogene regulation is not always associated with cell death 
or survival. Instead, changes in oncogenes expression may regulate the 
function of major neurotransmitters that provide homeostatic balance between 
excitation and inhibttion, or inhibition of these oncogenes may play a critical role 
in the age-specific effects that the SNR and selective mkfbraln nuclei have on 
seizures. 
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Introduction 
Whal Is Epliep.y? 
Delln/llon: The phenomenon of recurrent nervous system seizures is termed 
epilepsy. The term derives from the Greek word epilambanein, and shares the 
same root as the verb 'to seize' or 'to attack'. 
Previously epilepsy was thought of as a demoniac disease and gradually 
acquired a particular meaning as an epileptic seizure (Temkin et al., 1971). 
Seizures are initiated when small clusters of brain cells emit rapid, 
synchronized, highly rhythmic and repetttlve electrical discharges. The 
dysregulalion, first localized lo a small area expands within seconds lo involve 
the entire brain and can range from a brief episode lo a massive, prolonged, 
life-threatening convulsion. PaUents experience strange sensations, altered 
emotions, muscle spasms, and loss of coesoousness (Hesdorffer el al., 1998). 
When seizures last more than 30 minutes without interruption, patients are 
considered to be in status epilepticus (Delorenzo et al., 1992). Mortaltty from 
status epilepticus depends, aside from duration, on etiology, age, gender, race, 
and history of epilepsy (Towne el al., 1994). 
Approximately 2.3 million Americans of all ages are affected by epilepsy 
and 181,000 new cases are diagnosed with epilepsy and experience seizures 
each year (Hauser WA, 1998). Approximately 10"k of Americans will experience 
seizures in their life times and 3% by the age of 75 develop epilepsy (Begley, et 
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al 1998). Death rates are also elevated In individuals suffering from epilepsy, 
especially when seizures are not controlled (Langan, 2000). The severity of 
epilepsy varies among individuals. Most seizures are of a brief duration and 
generally subside wnhout treatment. In oontrast, some seizures of longer 
duration are very difficult to stop even with aggressive drug regiments (Begley 
et al., 2001). 
Temporal Lobe Epllapsy In the Mature Brain 
Complex partial seizures are one of the most common seizure types 
enoountered in adults (Deonna el al., 1986). The epileptic activity propagates 
through vulnerable regions such as the hlppocampus (HF), cortex, thalamus 
and substantia nigra (SN). Damage Is later found in all of these limbic brain 
structures. However, hippocampal sclerosis is the hallmark of the disease. The 
HF is located in the midbrain and consists of two regions, dorsal and ventral 
(Alaike et al., 1998). Several studies indicate that the HF and amygdala have 
close anatomic and physiologic Interactions, and initiation of the limbic seizure 
is likely a result of interaction between these structures (Alaike et al., 2001 ). In 
patients wnh intractable TLE the HF undergoes about 50-70"k damage and the 
amygdala about 30-60% (Bruton, 1988; Miiier et al., 1994). Since the HF is 
aHected and is known to be Involved in learning and memory, many studies 
have established that temporal lobe epilepsy (TLE) may impair memory abilities 
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(HermaM et al., 1992), auditory perception processing (Kester et al., 1991) and 
global visual processing (Doyon et al., 1991 ). 
Temporal Lobe Epilepsy In Ch/ldllKI 
In humans, temporal lobe epilepsy (TLE) is common in adults but also 
prevalent to a lesser extent In children (Hauser et al., 1975). However, 
maturation reduces the amount of tonic and myoctonic components and 
frequency of epileptic spasms (Fogarasi et al., 2002). Temporal lobe epilepsy 
(TLE) in children is found within the anterior temporal areas (Jambaque et al., 
2001). Seizures occur mostly in young children, especially in the first year of the 
life (Fogarasi et al., 2002). 
Focal seizures ol temporal lobe origin in infants may seem generalized 
clinically. The abnormalities associated with seizures of temporal lobe origin in 
young children consist of dysptasias, migrational disorders, and low-grade 
tumors (Harvey et al., 1997). ne in childhood can produce mental retardation, 
language disorders, attention and memory disturbances, neurobehavioral 
problems, and leamlng disabilities (Stafstrom et al., 1993; Holmes et al, 1997). 
The ea�y stages of development are a critical time in which seizures and SE 
may have more detrimental effects than in the mature brain. Neonatal seizures 
are particularly important since they are frequently associated with high 
mortalily and morbidity, and may often be the only sign of central nervous 
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system dysfunction (Aicardl and Chevrie, 1970; Delorenzo et al., 1992; Dodrill 
and Wilensky, 1990; van Esch et al., 1996). 
Experimental Models of TLE 
Kainic acid (KA) Is a potent neurotoxin and analogue ol glutamate that 
induces limbic seizures in adult and newborn experimental animals, but with 
different intensity, behavioral phenotype and neuropathological consequences. 
In adults the damage closely resembles human temporal lobe epilepsy 
(Corsellis and Bruton, 1988: Sutula et al., 1989; Ben-Ari, et al., 1981). Other 
parallels between KA-induced status epilepticus in adult rats and TLE in 
humans include: partial seizures with secondary generalization and blockade 
with antagonists (e. g. bendzodiazepine, pentobarbital). Two main patterns of 
neurodegeneration described in rats follqwing an I. p. KA injection include: (i) 
acute damage to extra-hippocampal structures such as the amygdale, 
entorhinal and piriform cortex, and thalamus that occurs between 6-24h 
following the onset of status epilepticus (Ben Ari, 1985; Friedman et al., 1994; 
Gramsbergen and Van den Berg, 1994). Damage in the temporal lobe typically 
precedes the appearance of seizures in several models (Mello et al., 1993; 
Nissinen et al., 2000). However, damage in the HF is associated with prolonged 
seizures (Jackson et al., 1998). The kindling model of TLE also suggests that 
repeated seizures cause selective loss of neurons in the HF (Cavazos and 
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Sutula, 1990) and amygdala (Tuunanen et al., 1997) in adults. 
A�nt S.lzurea and Damage 
Development of spontaneous seizures is age-dependent. Clinical studies 
and experimental models of epilepsy demonstrate that the immature brain 
develops and propagates seizures more readily than the mature brain (Moshe 
et al., 1983; Albala et al., 1984; Cavalheiro et al., 1987; Hauser et al., 1996). 
Hippocampal volume reduction is often associated with partial complex seizures 
at young ages (Saga and Oxbury, 1987; Lawson et al., 2000). 
In rodents, the period or maximal seizure susceptibility appears in the 2"' 
and 3"' weeks of postnatal life (Albala et al., 1984; Cavalheiro et al., 1987). 
Despite a higher propensity towards seizures, the immature brain is relatively 
resistant to neurodegeneration in response to a single episode of KA-induced 
status epileplicus (Nttecka et al., 1984; Holmes et. al., 1988; Friedman et al., 
1997; Sperber et. al., 1999). In contrast, KA Ind� seizure in perpubital rats 
leads to damage in CA1 that follows this resistant period (Sankar et. al., 1998). 
Rats younger then 30 days of age rarely develop spontaneous seizures 
(Stalstrom et al., 1992). Molecular mechanisms underlying delayed selective 
neuronal cell death associated with epilepsy remain unknown. in adult animals, 
molecular studies heve shown that many genes may be altered following 
induction of seizures in various epilepsy models. 
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TIHI Role of Ille Substanlla Nlgra In Age-dep,,ndent S.Jzures 
The SN is a small nucleus located in the ventral midbraln. This nucleus 
contains dopaminergic (DOPA) neurons, which are detected by the presence ot 
lhe dark-colored pigment called neuromelanin. SN consists anatomically of two 
main parts: the substantia pars compacta (SNC), which is composed of a sheet 
of DOPA neurons whose dendr�es varicose project into the second part, the 
pars reticulata (SNR) which consists of inhibitory neurons with y-aminobutric 
acid (GABA) as their primary neurotransmitter (Fallon et al., 1995). In the SNR. 
DA released from the dendrites of DOPA neurons plays an essential role In the 
basal ganglia outflow; finally, the SNC acts as a center for the propagation of 
the seizure, and the SNR plays an Important rote as lhe center of lhe Inhibitory 
system of status epiiepticus (Fan etal., 2QOO). 
Programmed Cs/I OIJIJth 
Programmed cell death acts to shape the final complement and 
arrangement ot lhe neurons in all neocorticai regions (Chun and Schatz 1999). 
Programmed cell death during development has traditionally been thought to 
resutt after a competttion for a limited supply of trophic support by differentiating 
neurons leaves some cells deprived of essential growth promoting factors 
(Oppenheim, 1991). This process has generally been thought to occur after 
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birth with the majority of cell death taking place poslnatally. More recently, cell 
death has been found to occur extensively during embryonic development, 
possibly occurring even during slages of cell proliferation (Kuida et al., 1998). 
During developmenl of the nervous system, approximately 50% of the 
neurons that originally formed are eliminated (Oppenheim et al., 1991). The 
extent ol neuronal survival is dependent on the production of neurotrophic 
molecules, which are produced by the targel tissue. Only those neurons 
receiving sufficient neurotrophic factor from the target tissue continue to 
prolfferate and differentiale, whereas others are lost through programmed cell 
death, a process called apoplosis (Melzslein el al., 1998; Sastry and Subba 
Rao, 2000). Apoptosis may play a role in neurodegenerative diseases and 
aging (Saslry and Subba Rao, 2000). 
Bc/-2 Family of Profo-oncogern,s 
The Bcf·2 family of proto-oncogenes is 'recognized as a common 
regulator of multiple apoptotic pathways (Reed et al., 1994). The Bcf-2 family 
can be separated into two functionally distinct groups, the anli-apoptotic Bc�2. 
�x and Bcl·w, and the pro-apoptotic Bak and Blk proteins (Akao et al., 1994; 
Tsujimoto et al., 1987). These proteins have been identffied as repressor or 
effector proteins, in different models of apoptolic neurodegeneration. Bcf-2 is a 
25kDa membrane-bound protein (Akao, el al. 1994; Hockenberry et al., 1990; 
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and Tsujimoto et al. 1986) that can block neuronal apoptosis in the developing 
brain (Allsopp et al. 1993; Garcia et al., 1992). Bcl-2 is localized in the 
mitochondrial membrane, in the nuclear envelope and in the endoplasmic 
reticulum (Hockenbeny et al., 1990). Bax, another member of the Bc�2 family, 
accelerates apoptotic cell death (Oltvai et al., 1993; Vekrellis et al., 1997). 
However, the level ot activation of the Bax protein can be post-translationally 
regulated by Bcl-2, thus suggesting the existence of a feedback mechanism 
that may help to maintain the ratio or Bcl-2 to Bax protein in a physiologically 
appropriate range (Oltvai et al., 1993; sedlack et al., 1995). 
There is growing evidence that the Bcl-2 family of proteins controls the 
activation of apoptotic effectors such as cytochrom c and Apaf-1 in the caspase 
pathway in developmental models exhibiting neurodegeneration. In the caspase 
pathway, members or the "BH3-domairror,ly' subset ot the Bc�2 family of 
proteins connect proximal death signals to the core apoptotic pathway (Green, 
2000; Kroemer, et al. 1999; Adams et al. 1998; Gross et al. 1999 and Huang et 
al. 2000). After activation or CD95 (Fas) or TNFR1 death receptors, BID is 
cleaved and activated as p15 IBID (Gross et al 1999). Activation of Bax has 
been proposed to initiate release of cytochrom c, and activation of Apaf-1, 
Caspases-9 apoptosome and addttional downstream effector caspases (Li et 
al., 1998, figure 1). 
Bcl-2 homodimerizes with ttseH and forms heterodimers with Bax In 
tO 
regulating certain forms of apoptotic cell death. The ratio between anti-apoptotic 
and pro-apoptotic members is important for determining whether cell death is 
Initiated or not (Sato et al .• 1994; Oltvai et al., 1993; sedlack et al., 1995). 
Decrease In the basal expression of Bcl-2 might In this case lead to 
Inappropriate cell death and might contribute to the development of 
degenerative diseases. Bc�2 mRNA is expressed In the SN, which contains the 
dopaminergk: neurons that degenerate In Parkinson's disease. 
In the normal nervous system of the rat, during development and 
adulthood, the Bc�2 mRNA Is localized In neurons and the level of the Bci-2 
protein is higher in the developing brain than the adult brain (Frankowski et al., 
1995). Bci-x and Bax genes are also expressed in rat brains. High levels of Bax 
are observed In the adult brain in contrast to Bci-2 (Krajewski et al 1994; Green, 
2000; Kroemer, et al. 1999). Bci-2, Bcl-l and Bax mRNA and protein are all 
expressed in the CA 1, CA2, and CA3 of the HF and in the ischemic transient 
infant rat brain (Ferrer et al 1997). 
In the current study, we examined Bcl-2 and Bax expression following 
KA administration of convulsant doses to young rats. lmmunohistochemistry 
and doubkt-staining immunofluorescence with antibodies to these proteins were 
used in combination with In situ hybridization for the corresponding mRNA to 
assess Bc�2 and Bax expression at times and ages associated with cell death 
and survival. The exact localization, expression and distribution of Bcl-2 and 
II  
Bax is a key piece of information for understanding the role of these proto­ 
oncogenes following seizure induced excltotoxicily. However, dissociation 
belween neurotoxcicity and proto-oncogene expression was observed in our 
study. For example, we found that both Bc�2 and Bax proteins and mRNA were 
sustained aHer KA induction in the HF except in areas of cell injury and they 
were reduced in brain areas that survive the seizure at the ages examined. 
Many studies have shown that mRNAs encoding a variely of genes are up 
regulated in KA resistant regions such as in the dentate gyrus. KA4nduced 
status epileplicus in adult rats does not produce changes in Bax and Bcl·2 
expression that correlate with the delayed pattern of neuroctegeneration. 
Expression of prolo-oncogenes in developmental epilepsy as a potential 
neuroprotective mechanism has not been previously explored. 
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Exper1menta1 Dulan 
Young Sprague-Dawley rats were obtained from Taconic Laboratories 
Inc. German town, NY) al least 5 days prior to any experimental procedures. 
The rats were weighed al lhe start of the experimenls and randomly grouped for 
experimental (n=7) and control (n=4). At postnatal (P) day 13 (P13), the animals 
experienced seizures by receiving an intraperitoneal injection of 2.5 rowKg of 
kainic acid. At P20, they received 7ffi!>'!<g and al P30 they received 12-mg/kg 
injections. The control animals received intraperitoneal injections of PBS. KA 
injections produced age dependent ettects in the experimental group. P13 pups 
exhibited squealing, wet dog shakes, stiff tails, head and body tremors, and 
shivers. Response to KA changed wilh increasing In age. At P20 and P30 
response to KA included: wet-dog-shakes, falling over, head nods, occasional 
lorelimb clonus, jumping and salivation and tonic·<:lonic convulsions. 
Only rats exhibiting increased locomotor activity about 30 minutes after 
the Injection of the KA followed by rapid "wet-dog" shakes and recurrent tonic­ 
clonic convulsions were used in these studies. At the completion of the 
experiments al 48 and 72 h after KA admlnislralion, rats were sacrificed by 
injection of penlobarbital loliowed by perfusion through lhe heart with pre-chilled 
4% parafonnaldehyde (PFA) in phosphate buttered saline (PBS). The brains 
were rapidly removed and fixed in 4% PFA In PBS for 6-8 hours, then 
transferred to cold PBS lor at least 24 hours prior lo processing for 
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immunohistochemical analysis. 
lmmunohlatochemlstty 
lmmunohistochemlstry was used to detennine the effect of seizure 
behavior on expression of Bax or Bc�2 that may affect cell death or survival. 
After the brains were fixed, the Vibratom was used to cut the HF and SN into 40 
µm sections. Sections were used for polyclonal and monoclonal antibody 
labeling. The rabbit polyclonal Bcl-2 antibodies (N-19, sc-492 Santa Cruz 
Biotechnology) were specific for epitopes corresponding to amino acids 4-21, 
mapping at the amino tenninus of human Bc�2 (identical to the corresponding 
domain of mouse Bcl-2). This antibody does not cross react with Bcl-x or Bax. 
The rabbit polyclonal Bax antibodies (N-20, sc-493, Santa Cruz Biotechnology) 
were specific for epitopes corresponding,to amino acids 43-61 of mouse Bax. 
This antibody is specific for Bax and does not cross-react with Bcl-2 or Bcl-x. 
The antibodies were used at dilutions of 1:100 and 1:200, for Bcl-2 and Bax, 
respectively. 
Histological sections were quenched, incubated in 0.1 % hydrogen 
peroxide in phosphate-buffered saline PBS, (to remove endogenous peroxidase 
activity) for 30 min, and then washed with PBS. Blocking was perfonned with 
5% normal goat serum (NGS) and 0.1% TrilonX-100 in PBS for 1 hour. 
Sections were then incubated with primary antibody to Bc�2 (1 :100), Bax (1: 
15 
200) over night at 4 •c. Sections were washed three times with PBS and 
Incubated with secondary antibody (Biotinylated anti rabbit lgG) for two hours. 
The sections were processed with Vectastain ABC kit (Vector tab Inc) at a 
dilution of 1: 100 for 45 min. Sections were visualized by diaminobenzidine 
(Vector Lab, SK-4100) as a chromogen. Sections were then heat dried onto 
gelatinized slides dehydrated, cleared, and covered with cover slips. 
Haematoxylin-Eosin staining was used for histology. 
Double nuor.sc,,nt lab<Jllng 
Tyrosine hydroxyfase 
Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the synthesis of 
dopamine and neuroepinephrlne (Serretti el al., 1998). The neurons in the SN 
are exclusively dopaminergic neurons. Sjnce these neurons are the source of 
strlatal DA, a major neurotransmitter responsible for motor funclions, their loss 
underlies the appearance of clinical motor disabillties (Dunnett et al., 1999). 
GABA mceptor 
The amino acid GABA has long been considered the major inhibitory 
neurotransmitter in the adult cortex (Connors et al., 1988; Kmjevic and 
Schwartz, 1967). GABA exerts Its effects by activation of ionotropic GABAA and 
metabotropic GABAe receplors (Bormann, 1988; Connors et al., 1988; Kaila, 
16 
1994). Glutamlc acid decarboxylase Gad is a unique enzyme for GABAergic 
neurons. GAD was used as a marker to Identify GABAergic neurons that co­ 
express Bax and Bci-2. 
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Methods 
Double lmmunofluorUCM!Ctl labeling 
For sequential double labeling, sections were dissected in Vibratom 
(same as single labeling). To remove endogenous peroxidase activity, sections 
were incubated for 15 min in 0.1% hydrogen peroxide. Sections were 
subsequenlly washed and non-specific binding was blocked with 5% normal 
goat serum. Primary rabbit antibodies to Bct-2 or Bax were used in dilutions of 
1:50 and 1:100 respectively. Mouse monoclonal TH (Chemicon, MAB318) in 
dilution of 1 :500 was used with the primary antibody. The sections that were 
incubated ovemtght at 4°C were washed three times in PBS. Sections were 
then Incubated for two hours at room t9nl)8rature with a 1:100 dilution of 
biotinylated goat anti-rabbit (Vector Laboratories, Burlingame, CA) and FITC 
goat anti-mouse to detect TH. Sections were then washed three times in PBS 
and incubated for 1 h at room temperature in a 1 :200 dilution of sterpto Avedin 
Texas Red {TX, Vector Labs). Sections were washed several times in PBS and 
after mounting were checked by immunotluorescence mk:roscope. 
In Situ Hybridization 
In situ hybridization was used to examine Bcl-2 and Bax mRNA 
expression at the level of HF and SN alter KA injection. For in situ studies the 
rats were decapitated alter 24 and 48 hours of SE and the brains frozen in pre- 
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chilled 2-melhylbutain and stored at -70 •c until use. 
In Situ Hybridization Hlstochemi.t,y 
Twenty-micron thick sections ol frozen brains were used for in situ 
hybridization. Sections were prepared from control and kalnic acid treated rats 
at 24 h and 48 h after KA administration. Sectioned tissues were transferred to 
poly-L-lysine-subbed slides (Poly-L-lysine, Sigma, p-1524). After the slides were 
air-dried, they were post fixed in 4% buffered PFA (para formaldehyde, Sigma 
p-6148) In PBS for 30 minutes. Sections were then acetylated in acetylation 
solution for 10 minutes at RT and washed twice in 2X SSC for 10 minutes. The 
sections dehydrated in SO"A., 75%, and were stored in 95% ETOH at 4"C until 
used. 
In Situ Hybridization Moi.culsr Biology 
Plasmid Preparation 
Standard bacterial culture media Luria-Bertani (LB) broth and agar plates 
were prepared as described by Sam brook et al (1989). Ampiciilin was added to 
LB 100µg,'ml. Overnight cultures of Bc�2. Bc�x and Bax were diluted to 1 :50 in 
LB broth plus ampicillin, and the subcultures were incubated with agitation at 
37"C. The cells were harvested by centrifugation, digested and plasmids were 
collected by Qiagen Plasmid Mini Kit (Qiagen, 12123) 
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Limiarization of Template with Restrict/on Endonuclease 
Bc�2 (full-length rat Bc�2 cONA is 708 bp, with the first and last 15 bp 
derived from mouse, Cell 1987 49:455-463) was linearized with EcoRI 
(Promega, R6017) and transcribed with T7 (promega, p2075) for the sense 
part. The anti sense part was linearized with Hind Ill (Prornega, and transcribed 
with T3 (Promega, p2083). Bax (rat Bax cDNA is 446bp, and corresponds to 
bases 85-53 of lhe human Bax cDNA, Endocrinology 1995 136:232-619) 
linearized with EcorV (promega, R6355) and transcribed using SP6 (promega, 
p1085) RNA polymerase. 
Probe Synthesis (cDNA) 
The 50 µI reaction mixture was prepared by mixing: 5µ1 of SX 
transcription buffer, 1.5µ1 rATP 10mM, 1.5µ1 rCTP 10mM , 1.5µ1 rGTPmM, 1.5µ1 
RNAse block II, 1.5µ1 DTT0.75M, 5µ1,35[S}-rUTP (1250Ci/mmol), 0.8 µg 
template, 2µ1 RNA Polymerase and DEPC water. The mixture was incubated for 
1 hat 37'C for T3, T7and Sp6 at 40'C. 
Probe Purification 
The probe was purified by adding 75µ1 of DEPC water and 100µ1 of 
chlorofonn, then centrifuged at 13000rpm for 5 min. The aqueous (upper) 
phase was collected and 100µ1 DEPC water was added to the remaining phenol 
phase and centrifuged for 5 minutes. The upper phase was then collected and 
combined with the original water phase. A 24:1 mixture ol 
20 
chlorolormfisoamylaloohol was added to the combined water phase and 
centrifuged for 2 min. The upper phase (200µQ was collected and combined 
with 40µ! of 10M NH4 acetate, and 900µ1 of Ice-cold 100% ETOH. The probe 
was precipitated by incubation at -7<Y'C over night and centrifuged at 12000 rpm 
for 45 minutes. The supernatant was carefully removed and the pellet air dried 
for 1-2 hours and resuspended in 40µ1 OEPC water. 
Pre-hybridization Solution 
The slides with brain sections were laid on a clean pad to dry. A ring of 
rubber or glue was made around the section. The humidttied chambers 
(Nalgene plastic boxes) were laid with filter paper and soaked with 50% 
formalin in OEPC water. The pre-hybridization solution was made with herring 
sperm 150µg/ml ONA, 2.5X Oenhardt's, 0.611.1 Nacl, 10mM Tris, 1mM EDTA, 
0.05% SOS, 50% deionized formamide, 0
1
05 mg/ml total yeast ANA and DEPC 
water. Slides were placed into a humidffied chamber and covered with pre­ 
boiled hybridization solution. Slides were incubated .at 49°C overnight. The next 
day the solution was removed by aspiration. The hybridization solution was 
mixed with probes calculated to ± 1 o' cpm/section and boiled for 5 minutes. The 
sections were hybridized overnight at 42°C in a buffer containing herring sperm 
150µg/ml ONA, 2.5X Oenhardt's, 0.611.1 Nad, 10mM Tris, 1mM EDTA, 0.05% 
SOS, 50% deionized formamide, 0.05mg/ml total yeast ANA, 10mM on and 
10% Oextran suttate. After hybridization the sections were washed briefly in 
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1XSSC for 30 min in a washing solution (50% forrnamlde (SIGMA F-7503), 1X 
SSC, 10mM OTT, and 44% water). The sections were treated with 20µg/ml 
RNAse buffer at RT for 20 min and washed twice wtth 0.2X SSC for 1 h. They 
were then dehydrated in 50%, 70"A,, and 95% ETOH. The slides exposed on 
Kodak X-Omat AR at -70 for 4-5 days. 
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Results 
lmmunohlatochemlat,y of Prat� 
In our studies, KA was injected into P13, P20 and P30 rats to determine 
the effects ol SE on Bax and Bcl-2 gene expression in the HF and SN. 
lmmunohistochemislry was used to determine the patterns of Bax and Bcl-2 
proteins in the HF and SN following KA-induced status epilepticus at three ages 
(P13, P20 and P30). In control animals al the three ages examined, the 
lmmunoreactivity of Bcl-2 and Bax were dense and prorninendy expressed 
throughout the HF. Labeling was localized In the cytoplasm and nucleus of 
neuronal cells as a fine granular precipitate within both the HF (CA 1,  CA2, 
CA3), and SN (pars reliculata and pars compacta). 
A�I S.lzure-lnducad Neurodegem,rallon 
Age dependent damage was gener,,.ted at the pyramidal cell layer of the 
HF at CA3. In P13, no damage was defected-at 48-72 h after status epileptlcus 
(figure 2, A and 8). In P20 pups as well, no damage was seen (figure 2, C and 
D). In contrast, at P30 lesions were seen 48-72 h after seizure termination 
(figure 2, E and F). This damage was detected In the pyramidal cell layer of the 
HF mostly in CA 1 and some in the CA3 region (figures 2, E and F). 
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Agure 2. lmmunohlstochamlstry of Bax (left panel) and Bcl-2 (right panel) 
72 h after KA treatmenL 
The immunoreactivity of the HF cell layers are preserved and condensed when 
compared with control animals at P13 (A·B) and P20 (C-D). In contrast, at P30 
lesions were seen 48-72 h after seizure tennination. This damage was detected 
in the pyramidal cell layer of the HF. mostly in CA3. The decrease in 
immunoreactivity seen wrth Bci-2 and Bax were associated with cell loss or 
injury (E·F). 
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In the SN, Bax and Bcl-2 immunoreactivity in control animals was 
unffonn and condensed. The strongest expression of Bax and Bc�2 protein was 
observed within the SNC, which contains dopaminergic neurons. In P30 
animals, depletion of Bax immunoreactivity was observed in the SN mostly in 
lhe SNC and pars reliculata al 48-72h posl-lcainic acid administration (figure 3). 
Al the lime examined, these age groups do not yet exhibit obvious cell loss or 
injury to the SN atter status epilepticus. 
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Figure 3. lmmunohlstochemlatry of Bax 72h after status epllepUcus In P30. 
A) Bax immunoreactivity in SN and parts of the mid tiraJn in control aninals was 
rob\Jst, shown at low magnification. B) High density of Bax immunolocalizatlon is 
seen In dopamlnargic naurons of the SNC. C-0) After seizure termination, there is 
a large-scale depletion of Bax expression in the SN and pans of the midbrain. 
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Bcl-2 protein stains unfformly and intensely in control aninals, and is 
prominently expressed throughout the SN (figure 4A). The Bcl-2 
lmmunoreactivity was greatly reduced in the SN, mainly in the SNA and SNC, 
following seizure termination at different time points of the study in P30 animals, 
when compared with control animal at the same age (figure 48). Haemaloxylin­ 
eosln staining of adjacent sections in the SN showed the intensity of the 
neuronal cell layer of the SN, SNC and SNR. There was no visible modification 
in the cell layer of the SN, and cells were unfform and unchanged. Hence, there 
was no apparent cell loss in this structure al this age (figure 4C). Down 
regulation of Bcl·2 accelerates programmed cell death in vitro, although 
decrease in Bcl-2 dioes not seem to Induce apoplosis per se. 
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Figure 4. Photograph of Bcl-2 In SN at P30. 
A) The schematic on the lett shows the Bcl-2 immunoreactivity of the SNC in 
lhe SN (with the high density of dopaminergic neurons in the SNC) In control 
animals. B) Bcl-2 protein is depleted 48h atter seizure termination at P30. C) 
Haematoxytin-Eosin staining in adjacent sections of the SN shows that there 
was no apparent cell loss in this structure at this age. 
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In a/tu hybrldlzatton 
The probe described above was used to analyze the expression ol Bax 
mRNA in the HF and the SN. The results obtained with in situ hybridization 
revealed expression of the Bcl-2 and Bax mRNA in the HF at CA 1, CA2, and 
CA3. The signal detected by in snu hybridization is specific for Bcl-2 and Bax 
because hybridization under identical conditions with a sense probe showed 
minimal or no signal. The Bcl-2 mRNA signal was localized over the pyramidal 
neurons in the CA1-CA3 areas of the HF and the granule neuron in the dentals 
gyrus. In control animals the Bax mRNA signal in HF was found to be uniform 
and prominently expressed in CA 1-CA3 and in the dentals gyrus. Modification 
of the Bax mRNA signal in the HF was not observed in P13 animals at 24·48h· 
post kainic acid administration when compared with control animals. However, 
animals at the same age showed a slight increase in Bax mRNA signal in the 
' 
dentate gyrus at 24-48h following kainlc acid administration (figure 5). 
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Figure 5. In .nu hybridization of Bax In the HF al P14 In control and kalnlc 
acid treated rats. 
Bax mRNA was unchanged in control (A) and kainic acid treated (B) within the 
HF at P14. 
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The Bcl-2, Bcl-x and Bax mRNA were expressed throughout the SN in 
control animals. Th& strongest expression was seen In the SNC, which contains 
dopaminergic neurons. However Bcl-2, Bc�x and Bax mRNA expression 
detected In the SNR. which contains GABAergic neurons (figure 6). 
ModHications In the intensity of the Bax mRNA signal were observed at 24-48h 
after kainic acid administration. Decrease in Bax mRNA was observed in the 
SNC and to a greater degree in the SNR. which is similar to our previous 
immunohistochemistry results that showed a strong decrease in Bax protein 
expression in the SNC and SNR. In shu hybridization after generation of the 
auto radlograph slides were dipped In emulsion and individual cells labeled. The 
primary results StJggest that the cells are affected differentially and that 
decreases are not unHorrn. Some cells express low level of Bax and some cells 
express higher level. Emulsion dipped , sections showed that dopamlnergic 
neurons of SNC expressed higher levels of Bax compared to a subset of cells 
within the SNR. Also, some cells in the SNC showed similar mRNA levels 
compared with some cells in SNR (figure 7). 
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Agwe 6. In situ hybridization of Bcl-2 (A), Bcl-x (B), Bax(C) In control rats 
at P20, at the level of the SN. The Bcl-2, Bcl-x and Bax mRNA were 
expressed throughout the SN in control animals. The strongest expression was 
seen in the SNC, which contains dopaminergic neurons. 
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Figure 7: In •ltu hybridization ol Bax mRNA showed a dacreal8 In the SN, 
SNC, and In SNR. 
(A). Emulsion dipped sections showed that dopaminergic neurons ol the SNC 
expressed higher levels ol Bax compared to a subset ol cells within the SNR. 
Also some cell in the SNC showed similar mRNA levels CO<r4)8red with some 
cells in the SNR. 
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Double lmmuno flUOIYI•� L.abellng 
Double labeling was used to identify the cell types that would show a 
decrease or an increase In the expression ol Bax or Bc�2 as a consequence of 
the seizures. Since dopamine is the primary neurotransmitter of the SNC and 
GABA is that of the SNR, these were the first candidates to be chosen. An 
antibody to tyrosine hydroxytase (TH) was used to specffically identify 
Catecholamine (CAT) neurons in the sliced tissue sections and to provide a 
morphological marker of their axonal and dendritic processes. 
In control animals, the Bct-2 immunoreactivity was present In both SNC 
and SNR. The intensity of immunoreactions was higher in SNC than SNR 
(figure BA). Decrease in Bcl-2 immunoreactivity was observed at 72h after 
kalnic acid administration, which is in agreement with In situ and 
immunohistochemistry experiment (figure 88). 
Figure BC shows the appearance of the SN DA in a 40µ section from a 
saline-treated control rat. Figure 80 shows the section from rats treated with a 
single Injection of KA (11fl'll>'kg). Comparison of these two figures shows that 
there was no apparent cell loss in this structure at this age 
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Figure 8. Double lmmunofluotescence staining with Bcl-2 antibody (red) 
and TH (antibodies for Identifying dopamlnerglc neurone, green) to 
Identify the cell types exhibiting apoptoals. 
A) SN in control animal shows Iha high intensity is on SNC. B) SN in KA treated 
animal showed decrease in expression of Bcl-2. C) Dopaminerglc neurons of 
the SNC in control animals. 0) Oopaminergic neurons of the SNC show no 
signfficant change. 
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Figure 9: Co-localization of Bcl-2 and tyrosine hydroxylase. 
lrrvnunolluorescence double labeling with TH and FITC (green) exhibit that the 
dopaminergic neurons of the SN are only expressed in the SNC. Bcl-2 antibody 
labeled with TX (red) was expressed in both the SNC and SNR. 
Fig 10: Co-locallzallon of Bcl-2 and tyrosine hydroxylasa. The cells that 
co-express both Bcl-2 and TH at a higher magnification. 
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Figure 11. Double labeling ol Bcl-2 and TH. 
A) Double labeling ol Bcl·2 and TH shows co-localizalion with DA neurons. B) 
The cells that express both Bc�2 and TH are projecting toward the cells that 
only express Bc�2. and lhere is an interaction between these two types ot cells. 
Therefore, the projecting cells are non-GABAergic. 
Figure 12. Bax and GAD lmmunofluoreacence labeling. 
There was a decrease in expresstOO of Bax after KA treatment whereas the 
adjacent section showed that GAO levels were undisturtled. 
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Agure 13. QuanUflcallon of Bax and Bcl-2 72h after status eplleptlcus. 
72h after status epilepticus, there was a reduction in optical immunodensity. 
Dens�ometric analysis of lmmunolabelllng showed an approximately 50% 
reduction In oncogenes expression. 
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01scusalon and concJuslon 
Many previous studies have stressed the Importance of the HF as well 
as the SN in limbic seizures. The Bcl-2 family of proto-oncogenes, which 
encode specific proteins under different physiological and pathological 
conditions, regulates programmed cell death or apoptosis. Programmed cell 
death has been hypothesized to be a default pathway, which is kept under 
control in order to pennit cells to continue to exist and proliferate. The Bcl-2 
family (Bcl-2, Bax or Bcl-x) is differentially regulated in the SN and HF 
throughout development. Bcl-2 is one of the anti apoptotic proteins (a member 
of Bcl-2 family) that is critical lor post mitotic neuronal cells, and over­ 
expression µ,events degeneration ol botl) sympathetic and sensory neurons in 
vivo (Chol et al., 1995; Colins et al., 1980; Guamieri et al,. 1993) and in vitro 
(Nakayama et al., 1994). Additionally, Bcl-2 has rescued cells not only from 
apoptotlc but also from necrotic death (Ferrer et al., 1998). Mutant mice with 
deficient Bcl-2 show degeneration of sensory and sympathetic neurons during 
postnatal development (Michaelidis et al., 1996). Mice with mutations in the Bel· 
x (a member of Bcl-2 family) gene show massive apoptosis (Motoyama et al., 
1995), a phenomenon also seen in vitro (Roth et al., 1996). 
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Bcl-2, Bcl-x and Bax proteins and mRNA are expressed in adult and 
pups as well as in kalnic acid treated rats. We examined our hypothesis about 
why the immature brain is resislanl to seizure-induced damage, by using In situ 
hybridization for mRNA detection and immunohistochemistry for identifying the 
Bc�2 and Bax proteins, after administration of kalnic acid. We have 
demonstrated al P14 that the level of Bax mRNA and protein in HF was 
unchanged. In conlrasl at P20, down regulation of Bax mRNA occurred in the 
SN. But this structure did not show any detectable cell loss at two levels of the 
SN. Aceo<dingly, we have demonstrated the same results with double 
immunofluorescence labeling of DA and GABAergic neurons of this region. 
Interestingly, in P30, changes in Bax and f3cl-2 protein expression are observed 
72 h after kainic acid treatment in CA2 and CA3 of the HF, which is associated 
with cell loss. 
Emulsion dipped slides can label individual cells. The RNA data suggest 
that the cells were attected differentially and that their decrease is not unifonn. 
The dopaminergic neurons of the SNC express higher levels of Bax compared 
to the subset of cells within the SNR, and some of these cells show similar 
mRNA levels when compared with those with in the SNC. These may be 
different cell types like somatostatine cells or other types of cells. It is worth 
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stressing that Bcl-2 and Bax interactions, as posttive and negative regulators of 
eel death, are condttioned by their cellular localization. 
In the SNR, most of the GABA content Is associated with GABAergic 
neurons. GABA content prevents the spread of seizures. We examined with TH 
enzyme to DA neurons and GAO to GABAergic neurons. We found that the DA 
content was sustained in the same neurons that down regulate Bax and Bcl-2 
genes. In other words, the DA neurons of the SNC and GABAergic neurons of 
the SNR were undisturbed despite the prolonged seizures. Therefore, 
decreases in the SN were not mattunction of these cells of their 
neurotransmitters and indicate the cells were still cell healthy. What remains to 
be clardied are the structural ·moddipalions that can compromise the 
localization, dimerization and function of Bax with other members of the Bci-2 
family in the nucleus following lcainic acid excitotoxicity. 
In the present study we show that that down regulation of these proto­ 
oncogenes is not associated wtth consistent patterns of Bcl-2, Bci-x and Bax 
protein or mRNA in sensttive regions such as the HF or SN. In fact, our results 
suggest that inhibition of Bax and Bci-2 proto-oncogenes may play a critical role 
in the age-specific effects that the SNR has on seizures. One hypothesis is that 
diown regulation of proto-oncogenes may cause tolerance by raising the seizure 
threshold to prevent development of spontaneous seizures. 
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Inhibition ol Bax and Bcl-2 p,oto-oncogenes may play a critical role in 
these age-specific effects. In perpubital ralS, a simultaneous reduction ol Bax 
and Bcl-2 mRNA and protein expression following KA induction of seizures In 
the SNC and SNR caused no apparent Increase in apoptosls. Taken together, 
the present data shows that the cells express oncogenes may act as a relay 
center to regulale excitation and Inhibition between neurons of lhe SN 
compacta and SN reticulata. Thus, classical activa�on ol Bax lo iniliale release 
of cytochrom c, activalion of Apaf-1, caspase-9, and other downslream 
effectors caspases to induce cell dealh (Li el al., 1997) does nol appear to 
apply in lhis model. Altered Bcl·2 and Bax protein patterns play a crilical role in 
the age-specific effects lhat the SNR and seleclive midbrain nuclei have on 
seizures by affecting upstream lransmitler nuclear syslems. Therefore, ii is 
importanl to further characlerize lhese 'proto-oncogenes within lhe DA and 
GABAergic neurons of the SNC and SNR lo elucidale components underlying 
age-dependenl regulation of seizures. Understanding the rote of lhese 
oncogenes on seizure lhresholds during the poslnatat period and seizure­ 
induced brain damage thal occurs laler in lne will impacl disease management 
lor seizure disorders at different ages. 
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